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Mobile elements such as transposons and retrotrans-
posons constitute a substantial fraction of eukaryotic
genomes. Such elements represent ~45% of the human
genome. Long INterspersed Element-1 (LINE-1 or L1)
constitutes about 17% of human DNA and is the only
known autonomously active human retrotransposon. L1s
are bi-cistronic elements that encode two proteins, ORF1p
and ORF2p, which are essential for retrotransposition.
These proteins associate with the RNA from which they
were translated to form an L1 ribonucleoprotein particle
(L1-RNP), which is a hypothesized retrotransposition
intermediate. The insertion of a new L1 copy occurs by a
mechanism known as target-site primed reverse transcrip-
tion (TPRT), which is performed by the endonuclease and
reverse-transcriptase activities of ORF2p and possibly
other cellular factors. About 80 to 100 L1s per human
genome retain the ability to retrotranspose by this mech-
anism, and therefore the ongoing mobility of L1 elements
contin! ues to impact the evolution of our genome.
Here, we developed new molecular tools to detect retro-
transposition-competent L1 RNA and proteins through an
epitope-tagging strategy. We used a biochemical approach
to identify the 'basal' retrotransposition complex contain-
ing L1 RNA, epitope-tagged ORF1p and epitope-tagged
ORF2p. We also tested retrotransposition-deficient L1s for
their ability to form RNPs and to encode an ORF2p-spe-
cific reverse transcriptase activity. Using immunocyto-
chemistry coupled with FISH, we observed a cytoplasmic
accumulation of L1 RNPs in perinuclear foci in associa-
tion with stress granules (SG). Interestingly, we observed
that the SG protein markers consistently surrounded the
L1 RNP foci. Point mutations in the RNA binding domain
of ORF1p decreased the ability of the L1 proteins to form
cytoplasmic aggregates, and confirmed the role of this
domain in L1 RNP formation. Thus, these results further
our understanding of the L1 RNP complex and the general
mechanism of L1 retrotransposition.
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